Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19
- PMID: 32923613
- PMCID: PMC7457335
- DOI: 10.1126/sciadv.abc1463
Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19
Abstract
Bacillus Calmette-Guérin (BCG) vaccination may reduce the risk of a range of infectious diseases, and if so, it could protect against coronavirus disease 2019 (COVID-19). Here, we compared countries that mandated BCG vaccination until at least 2000 with countries that did not. To minimize any systematic effects of reporting biases, we analyzed the rate of the day-by-day increase in both confirmed cases (134 countries) and deaths (135 countries) in the first 30-day period of country-wise outbreaks. The 30-day window was adjusted to begin at the country-wise onset of the pandemic. Linear mixed models revealed a significant effect of mandated BCG policies on the growth rate of both cases and deaths after controlling for median age, gross domestic product per capita, population density, population size, net migration rate, and various cultural dimensions (e.g., individualism). Our analysis suggests that mandated BCG vaccination can be effective in the fight against COVID-19.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Figures


Similar articles
-
The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.Vaccine. 2020 Sep 22;38(41):6374-6380. doi: 10.1016/j.vaccine.2020.08.018. Epub 2020 Aug 10. Vaccine. 2020. PMID: 32798142 Free PMC article. Review.
-
Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.Asian Pac J Allergy Immunol. 2020 Sep;38(3):150-161. doi: 10.12932/AP-310520-0863. Asian Pac J Allergy Immunol. 2020. PMID: 32686943 Review.
-
Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?Future Oncol. 2020 Jul;16(19):1323-1325. doi: 10.2217/fon-2020-0381. Epub 2020 May 14. Future Oncol. 2020. PMID: 32406253 Free PMC article. No abstract available.
-
Impact of Routine Infant BCG Vaccination on COVID-19.J Infect. 2020 Oct;81(4):625-633. doi: 10.1016/j.jinf.2020.08.013. Epub 2020 Aug 12. J Infect. 2020. PMID: 32795481 Free PMC article.
-
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17720-17726. doi: 10.1073/pnas.2008410117. Epub 2020 Jul 9. Proc Natl Acad Sci U S A. 2020. PMID: 32647056 Free PMC article.
Cited by
-
Machine-Learning-Assisted Analysis of TCR Profiling Data Unveils Cross-Reactivity between SARS-CoV-2 and a Wide Spectrum of Pathogens and Other Diseases.Biology (Basel). 2022 Oct 19;11(10):1531. doi: 10.3390/biology11101531. Biology (Basel). 2022. PMID: 36290433 Free PMC article.
-
Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development.Front Immunol. 2023 Feb 21;14:1129705. doi: 10.3389/fimmu.2023.1129705. eCollection 2023. Front Immunol. 2023. PMID: 36895557 Free PMC article.
-
SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults.JAMA. 2020 Jun 9;323(22):2340-2341. doi: 10.1001/jama.2020.8189. JAMA. 2020. PMID: 32401274 Free PMC article.
-
Effectiveness of Bacille Calmette-Guerin vaccination policies in reducing infection and mortality of COVID-19: a systematic review.Glob Health Res Policy. 2022 Nov 7;7(1):42. doi: 10.1186/s41256-022-00275-x. Glob Health Res Policy. 2022. PMID: 36336688 Free PMC article.
-
Worldwide inverse correlation between Bacille Calmette-Guérin immunization and COVID-19 mortality.Res Sq [Preprint]. 2020 Sep 28:rs.3.rs-42927. doi: 10.21203/rs.3.rs-42927/v2. Res Sq. 2020. Update in: Infection. 2021 Jun;49(3):463-473. doi: 10.1007/s15010-020-01566-6. PMID: 32702715 Free PMC article. Updated. Preprint.
References
-
- Aronson N. E., Santosham M., Comstock G. W., Howard R. S., Moulton L. H., Rhoades E. R., Harrison L. H., Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA 291, 2086–2091 (2004). - PubMed
-
- World Health Organization , BCG vaccines: WHO position paper—February 2018. Wkly. Epidemiol. Rec. 93, 73–96 (2018). - PubMed
-
- Colditz G. A., Brewer M. F., Berkey C. S., Wilson M. E., Burdick E., Fineberg H. V., Mosteller F., Efficacy of BCG vaccine in the prevention of tuberculosis: Meta-analysis of the published literature. JAMA 271, 698–702 (1994). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical